Research

Medical Sciences

Title :

In vivo efficacy & safety studies of CSCR-ST04, the gene edited autologous hematopoietic stem cells for the gene therapy of beta-hemoglobinopathies

Area of research :

Medical Sciences

Focus area :

Research & Development, R&D

Principal Investigator :

Dr. S. Thangavel, Assistant Investigator, Centre for Stem Cell Research, Tamil Nadu

Timeline Start Year :

2019

Timeline End Year :

2022

Details

Total Budget (INR):

84,00,000

Organizations involved